Content area
Full Text
A 45-year-old woman with subclinical rosacea started receiving amlodipine 5mg [frequency and route not stated] for essential hypertension. She presented with worsening skin flushing 2 weeks later; redness on her cheeks had worsened a few days after amlodipine initiation, and she had observed a higher number of telangiectasias after 1 week of therapy. Amlodipine was replaced with ramipril, and her flushing frequency had decreased from constant to occasional after 2 weeks; telangiectasias consistently decreased.